Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absorption, Actym, Adenine, agonist, AMR, antimicrobial, appeal, ASR, attenuated, attrition, bacterial, bid, biopharma, Bioscience, Bioserra, Capricor, Carmine, carryforward, categorized, Charton, CJEU, closure, codevelopment, Codiak, Commissioner, confronted, contractor, covenant, Coya, CSE, CSR, cure, DDS, deep, delisting, deployment, depth, derecognition, derecognized, detour, Didier, disciplinary, dominated, Eudravigilance, EV, EVs, excise, Exopharm, Fayet, Functionaly, gave, GIMV, GlaxoSmithKline, grace, Helsinn, Hoch, hub, idled, IDTA, immature, ImmuneSensor, impede, impression, indefinitely, ineligible, infectiology, inflammatory, Informatique, Inline, Intelligence, invaded, iPSP, jointly, judgement, Karine, lag, licensee, Linkbase, Maat, MC, MDImune, Medidata, Mersana, Microphyt, morale, motivate, naked, Nanoparticle, neurologic, NH, Nissle, Omnispirant, opined, outpace, pathogenic, penalize, phage, PhagoDAIR, player, PSE, Quantum, rapporteur, readout, recalculating, recognised, reconcile, reconciled, redundancy, reestimated, regain, regained, REGENT, remote, reorganization, resistance, resistant, restart, runway, Sanquin, Schema, semester, senescence, sensitive, Shield, ShiftBio, shortly, spring, standalone, Steering, STINGa, successor, Synlogic, Takeda, Taxonomy, technique, Theraguix, Thibaut, Township, transformation, Troy, true, trybeca, Typhimurium, unbilled, unmodified, unplanned, valorization, vesiculation, West, Windsor, withstand, XBRL
Removed:
AADA, abraxane, absolute, adenocarcinoma, ADI, administrated, advancement, ahead, Alexion, alternating, alternation, anaphylactic, anemia, anniversary, arginine, astrazeneca, BioLineRx, BRCA, broaden, built, BVF, capivasertib, centered, China, companion, comprise, conceptual, constructed, contaminated, Cornell, culture, defective, deiminase, demonstrably, designing, desire, developmental, devoting, discontinue, distancing, distinction, documented, donation, EGC, Eleison, experiencing, extinguish, FIFO, filer, fixture, Floor, fluorouracil, flurouracil, Francisco, furlough, gamma, geographic, germline, globally, glufosfamide, glutamyl, golden, hemorrhage, hiring, interrupted, intravenously, ipatasertib, irinotecan, Jazz, Jumpstart, Lampert, leucovorin, liposomal, LP, Lynparza, mark, meantime, methionine, MGL, mutant, myeloid, neutropenia, nonbinding, nonconvertible, obsolescence, Onivyde, operator, oppose, opted, optionally, outbreak, oxaliplatin, parachute, PARP, pecuniary, periodically, PLC, polymerase, predicted, premature, prematurely, publication, Radboud, realizable, reclassified, regulator, repeat, restructured, ribose, robust, San, Sansome, satisfying, Seattle, segregation, Servier, ship, shock, strain, sublicense, substituted, surfaced, switch, switching, SynCore, synergistic, Talzenna, Tecentriq, transferase, ultimate, undermine, undermined, undetected, unforeseen, unsecured, validation, vedotin, vii, viii, Wuhan
Filing tables
Filing exhibits
PHXM similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements Nos. 333-265927, 333-255900, 333-239429, 333-232670, and 333-222673 on Form S-8 and Nos. 333-248953 and 333-259690 on Form F-3 of our reports dated March 28, 2023, with respect to the consolidated financial statements of Erytech Pharma S.A and the effectiveness of internal control over financial reporting.
Lyon, March 28, 2023
KPMG S.A.
Stéphane Gabriel Devin
Partner